Amendment #33 to H4891
Responsibility to use compensation for benefit of covered persons
Mrs. LaNatra of Kingston moves to amend the amendment in section 35 by striking paragraph (b) in lines 767-773 and replacing it with the following new language:-
(b) All compensation remitted by or on behalf of a pharmaceutical manufacturer, developer or labeler, directly or indirectly, to a carrier, or to a pharmacy benefits manager under contract with a carrier, related to its prescription drug benefits must be:
(i) Remitted directly to the covered person at the point of sale to reduce the out-of-pocket cost to the covered person associated with a particular prescription drug; or
(ii) Remitted to, and retained by, the carrier. Compensation remitted to the carrier must be applied by the carrier in its plan design and in future plan years to offset the premium for covered persons.